Cargando…
P27 HIGH DOSE CYCLOPHOSPHAMIDE AS MOBILIZATION REGIMEN IN NEWLY DIAGNOSED MULTIPLE MYELOMA: SAFETY AND EFFICACY IN AN OUTPATIENT SETTING. SINGLE CENTER EXPERIENCE
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171715/ http://dx.doi.org/10.1097/01.HS9.0000936236.83735.8b |
| _version_ | 1785039482365411328 |
|---|---|
| author | Massarotti, L. Branca, A. Pavan, L. Maroccia, A. Cavarretta, C.A. Ruocco, V. Zatta, I. Scapinello, G. Piazza, F. D’Amore, F. Lessi, F. Gurrieri, C. Zambello, R. Trentin, L. Berno, T. |
| author_facet | Massarotti, L. Branca, A. Pavan, L. Maroccia, A. Cavarretta, C.A. Ruocco, V. Zatta, I. Scapinello, G. Piazza, F. D’Amore, F. Lessi, F. Gurrieri, C. Zambello, R. Trentin, L. Berno, T. |
| author_sort | Massarotti, L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10171715 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101717152023-05-11 P27 HIGH DOSE CYCLOPHOSPHAMIDE AS MOBILIZATION REGIMEN IN NEWLY DIAGNOSED MULTIPLE MYELOMA: SAFETY AND EFFICACY IN AN OUTPATIENT SETTING. SINGLE CENTER EXPERIENCE Massarotti, L. Branca, A. Pavan, L. Maroccia, A. Cavarretta, C.A. Ruocco, V. Zatta, I. Scapinello, G. Piazza, F. D’Amore, F. Lessi, F. Gurrieri, C. Zambello, R. Trentin, L. Berno, T. Hemasphere Poster Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10171715/ http://dx.doi.org/10.1097/01.HS9.0000936236.83735.8b Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Poster Massarotti, L. Branca, A. Pavan, L. Maroccia, A. Cavarretta, C.A. Ruocco, V. Zatta, I. Scapinello, G. Piazza, F. D’Amore, F. Lessi, F. Gurrieri, C. Zambello, R. Trentin, L. Berno, T. P27 HIGH DOSE CYCLOPHOSPHAMIDE AS MOBILIZATION REGIMEN IN NEWLY DIAGNOSED MULTIPLE MYELOMA: SAFETY AND EFFICACY IN AN OUTPATIENT SETTING. SINGLE CENTER EXPERIENCE |
| title | P27 HIGH DOSE CYCLOPHOSPHAMIDE AS MOBILIZATION REGIMEN IN NEWLY DIAGNOSED MULTIPLE MYELOMA: SAFETY AND EFFICACY IN AN OUTPATIENT SETTING. SINGLE CENTER EXPERIENCE |
| title_full | P27 HIGH DOSE CYCLOPHOSPHAMIDE AS MOBILIZATION REGIMEN IN NEWLY DIAGNOSED MULTIPLE MYELOMA: SAFETY AND EFFICACY IN AN OUTPATIENT SETTING. SINGLE CENTER EXPERIENCE |
| title_fullStr | P27 HIGH DOSE CYCLOPHOSPHAMIDE AS MOBILIZATION REGIMEN IN NEWLY DIAGNOSED MULTIPLE MYELOMA: SAFETY AND EFFICACY IN AN OUTPATIENT SETTING. SINGLE CENTER EXPERIENCE |
| title_full_unstemmed | P27 HIGH DOSE CYCLOPHOSPHAMIDE AS MOBILIZATION REGIMEN IN NEWLY DIAGNOSED MULTIPLE MYELOMA: SAFETY AND EFFICACY IN AN OUTPATIENT SETTING. SINGLE CENTER EXPERIENCE |
| title_short | P27 HIGH DOSE CYCLOPHOSPHAMIDE AS MOBILIZATION REGIMEN IN NEWLY DIAGNOSED MULTIPLE MYELOMA: SAFETY AND EFFICACY IN AN OUTPATIENT SETTING. SINGLE CENTER EXPERIENCE |
| title_sort | p27 high dose cyclophosphamide as mobilization regimen in newly diagnosed multiple myeloma: safety and efficacy in an outpatient setting. single center experience |
| topic | Poster |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171715/ http://dx.doi.org/10.1097/01.HS9.0000936236.83735.8b |
| work_keys_str_mv | AT massarottil p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience AT brancaa p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience AT pavanl p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience AT marocciaa p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience AT cavarrettaca p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience AT ruoccov p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience AT zattai p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience AT scapinellog p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience AT piazzaf p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience AT damoref p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience AT lessif p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience AT gurrieric p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience AT zambellor p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience AT trentinl p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience AT bernot p27highdosecyclophosphamideasmobilizationregimeninnewlydiagnosedmultiplemyelomasafetyandefficacyinanoutpatientsettingsinglecenterexperience |